Plasma myostatin measured by a competitive ELISA using a highly specific antiserum

Clinica Chimica Acta

Volumn 413, Issue 15-16, 2012, Pages 1288-1294

  Wintgens, Karl Florian ^a   Dschietzig, Thomas ^a   Stoeva, Stanka ^a   Paulsson, Mats ^b   Armbruster, Franz Paul ^a  

^a IMMUNDIAGNOSTIK AG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Anti serum; Heart failure; Immunoassay; Myostatin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIBODY; FOLLISTATIN; GROWTH DIFFERENTIATION FACTOR; GROWTH DIFFERENTIATION FACTOR 11; MYOSTATIN; MYOSTATIN ANTIBODY; UNCLASSIFIED DRUG;

ACCURACY; ADULT; AGED; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CALIBRATION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RELIABILITY; VALIDITY;

AGED; AGED, 80 AND OVER; ANIMALS; CASE-CONTROL STUDIES; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMANS; IMMUNE SERA; MALE; MIDDLE AGED; MYOSTATIN; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RABBITS; RECOMBINANT PROTEINS;

ORYCTOLAGUS CUNICULUS;

EID: 84861336140     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.04.023     Document Type: Article

References (28)

1. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
2. McPherron A.C., Lee S.J. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 1997, 94:12457-12461.
3. Bogdanovich S., Krag T.O., Barton E.R., et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002, 420:418-421.
4. Wagner K.R., McPherron A.C., Winik N., Lee S.J. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 2002, 52:832-836.
5. Wells D.J. Gene doping: the hype and the reality. Br J Pharmacol 2008, 154:623-631.
6. Acosta J., Carpio Y., Borroto I., Gonzalez O., Estrada M.P. Myostatin gene silenced by RNAi show a zebrafish giant phenotype. J Biotechnol 2005, 119:324-331.
7. George I., Bish L.T., Kamalakkannan G., et al. Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail 2010, 12:444-453.
8. Gruson D., Ahn S.A., Ketelslegers J.M., Rousseau M.F. Increased plasma myostatin in heart failure. Eur J Heart Fail 2011, 13:734-736.
9. Morissette M.R., Cook S.A., Foo S., et al. Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circ Res 2006, 99:15-24.
10. Sharma M., Kambadur R., Matthews K.G., et al. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 1999, 180:1-9.
11. Hittel D.S., Axelson M., Sarna N., Shearer J., Huffman K.M., Kraus W.E. Myostatin decreases with aerobic exercise and associates with insulin resistance. Med Sci Sports Exerc 2010, 42:2023-2029.
12. Rodgers B.D., Garikipati D.K. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev 2008, 29:513-534.
13. Lee S.J. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 2004, 20:61-86.
14. Wolfman N.M., McPherron A.C., Pappano W.N., et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci U S A 2003, 100:15842-15846.
15. Cheung W.W., Rosengren S., Boyle D.L., Mak R.H. Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int 2008, 74:180-186.
16. Ehehalt S., Schweizer R., Blumenstock G., et al. Investigation of myostatin serum levels before and after a 6-month lifestyle intervention program in obese children. Exp Clin Endocrinol Diabetes 2011, 119:238-242.
17. Zamora E., Simo R., Lupon J., et al. Serum myostatin levels in chronic heart failure. Rev Esp Cardiol 2010, 63:992-996.
18. Diel P., Schiffer T., Geisler S., et al. Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive immuno PCR. Mol Cell Endocrinol 2010, 330:1-9.
19. Shyu K.G., Lu M.J., Wang B.W., Sun H.Y., Chang H. Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. Eur J Clin Invest 2006, 36:713-719.
20. Hill J.J., Davies M.V., Pearson A.A., et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem 2002, 277:40735-40741.
21. Lee S.J. Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS One 2008, 3:e1628.
22. Lenk K., Schur R., Linke A., et al. Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model. Eur J Heart Fail 2009, 11:342-348.
23. Shyu K.G., Ko W.H., Yang W.S., Wang B.W., Kuan P. Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes. Cardiovasc Res 2005, 68:405-414.
24. Wang B.W., Chang H., Kuan P., Shyu K.G. Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway. J Endocrinol 2008, 197:85-93.
25. Heineke J., Auger-Messier M., Xu J., et al. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation 2010, 121:419-425.
26. Lenk K., Erbs S., Hollriege R., et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2011, [electronic publication ahead of print]. 10.1177/1741826711402735.
27. Lenk K., Schuler G., Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachex Sarcopenia Muscle 2010, 1:9-21.
28. Goetze J.P. Biosynthesis of cardiac natriuretic peptides. Results Probl Cell Differ 2010, 50:97-120.